Abstract: This paper introduces recent research results which are implemented at the recently founded Virtual Research Laboratory (VRL). VRL is aimed to apply recent results in research intensive ...

Boston Scientific was the worst performer in the S&P 500 Wednesday after the medical-device maker beat earnings expectations but offered a disappointing outlook for the current quarter.

With some luck, specialized equipment, a supervolcano and a narrow hole 30 stories deep, researchers demonstrated that earthquakes shake up more than just rocks—they also boost microbe populations ...

As requested by the General Assembly, the United Nations Secretary-General has launched an open call for candidates to serve on the Independent International Scientific Panel on Artificial ...

Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance that slightly fell short of elevated investor expectations. This response was ...

Analysts expect Uber to increase its revenue at an annual pace of 14% through 2027. They see 43% upside for the stock over the next 12 months. The stock market's day-to-day narrative can change on a ...

Established with Resolution A/RES/79/325 on 26 August 2025, the Independent International Scientific Panel on AI serves as the first global scientific body on Artificial Intelligence (AI), bringing ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...

Boston Scientific’s share price — which medical device competitors have long envied — sputtered Feb. 4 after the company reported softer sales than expected in its blockbuster division treating heart ...

Feb 4 (Reuters) - Boston Scientific (BSX.N), opens new tab on Wednesday reported lower-than-expected quarterly sales in its key electrophysiology division, dragging the medical device maker's shares ...

Boston Scientific (BSX) lost ~9% in the premarket on Wednesday after the MedTech giant indicated an underwhelming outlook for 2026 with its Q4 2025 results, which, however, beat Street forecasts ...